Targeting triple-negative breast cancer with momordicine-I for therapeutic gain in preclinical models

Authors

Kousik Kesh, Saint Louis University
Ellen T Tran, Saint Louis University
Ruchi A Patel, Saint Louis University
Cynthia X Ma, Washington University School of Medicine in St. Louis
Ratna B Ray, Washington University School of Medicine in St. Louis

Journal

Cancers

Publication Date

7-15-2025

Volume

17

Issue

14

First Page

2342

Document Type

Open Access Publication

DOI

10.3390/cancers17142342

Rights and Permissions

Kesh K, Tran ET, Patel RA, Ma CX, Ray RB. Targeting Triple-Negative Breast Cancer with Momordicine-I for Therapeutic Gain in Preclinical Models. Cancers (Basel). 2025 Jul 15;17(14):2342. doi: 10.3390/cancers17142342 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Kesh, Kousik; Tran, Ellen T; Patel, Ruchi A; Ma, Cynthia X; and Ray, Ratna B, "Targeting triple-negative breast cancer with momordicine-I for therapeutic gain in preclinical models." Cancers. 17, 14. 2342 (2025).
https://digitalcommons.wustl.edu/oa_4/5177

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.